Strategic Program Cancer nieuws
Strategic Program Cancer nieuws
"I'm a real tech guy"
How do diseases develop? How can we recognize them more quickly? And how can we treat them in a more targeted way? By analyzing very large amounts of molecular data with the latest developments in artificial intelligence (AI). This is what Jeroen de Ridder is dedicated to. As of 1 April 2024, he has been appointed as professor of bioinformatics in molecular biology at UMC Utrecht, within the Strategic Program Cancer.
Read moreFocus on side effects of immunotherapy
More research into the side effects of immunotherapy for cancer is highly needed. That is the message of researchers from Utrecht with their article in the journal Nature Cancer. These side effects vary widely, from skin rashes to inflammation of the heart. Focus on side effects of immunotherapy
Read moreFocus on older colorectal cancer patients
Colon cancer occurs mainly in older people. Yet, there is a striking lack of research specifically aimed at older patients with colorectal cancer. Researchers at UMC Utrecht want to change this. The aim is to provide a more effective, less burdensome tailor-made treatment for older people with metastatic colorectal cancer.
Read moreLieve Tytgat appointed professor of biomarkers
How can we better monitor the disease progression of children with solid tumors? That is the question Lieve Tytgat focuses on. As of 1 January 2024, she has been appointed professor of biomarkers in pediatric solid tumors at UMC Utrecht. She primarily focuses on the further development of blood and urine tests to better detect and monitor childhood cancer. "If necessary and possible, we can then adjust the treatment more quickly."
Read moreUMC Utrecht and Philips speed up development of image-guided treatments
UMC Utrecht and Philips are bringing together healthcare professionals, researchers and technicians in a 'fieldlab'. Here, they will develop new innovative technology and software to benefit healthcare. The goal is to devise less burdensome and more efficient treatments for patients, while at the same time realizing a more sustainable healthcare system.
Read moreNew study speeds up radiation therapy
A targeted radiation therapy that lasts only 15 minutes, instead of 45 minutes. Plus: an even more precise, real-time treatment of the tumor. These are the two goals of a new study by UMC Utrecht to further innovate the MR-Linac. NWO has granted 1.7 million euros to this research project.
Read moreFour new cancer research projects at UMC Utrecht receive Hanarth grants
How can artificial intelligence be used to improve treatment in cancer patients? Researchers from UMC Utrecht are working on this question. Four research projects at UMC Utrecht received funding for this from the Hanarth Fonds.
Read more'I learned to look at patients specifically'
Hans Merks, professor of paediatric soft tissue and bone sarcomas at UMC Utrecht, delivered his oration on Friday 2 February, titled 'Look and marvel'. A speech about sarcoma research, deeper layers that you only start to see when you realise it and the search for effective treatments for children.
Read moreUMC Utrecht generously rewarded by KWF
In what ways can immunotherapy be used more effectively against head and neck cancer, liver cancer, multiple myeloma and other tumor types? And how do we prevent children with thyroid cancer from being overtreated? These questions are being investigated in four new studies at UMC Utrecht. KWF Dutch Cancer Society is funding these projects, about which we tell you more below, with over three million euros in total.
Read moreWork out with metastatic breast cancer
Patients with metastatic breast cancer suffer less from their disease and the side effects of their treatment if they engage in physical training. They, for instance, are less tired, feel less pain and have increased their endurance. As a result, patients experience a better quality of life. This was shown in a comprehensive international study led by UMC Utrecht.
Read more